Vivos Historical Valuation

VVOS Stock  USD 3.38  0.18  5.62%   
Some fundamental drivers such as market cap or Vivos Therapeutics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Vivos Therapeutics valuation indicators such as Market Cap of 14.4 M or Working Capital of 0.0 to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Vivos Therapeutics's future value.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.

About Vivos Valuation Data Analysis

Valuation is the financial process of determining what Vivos Therapeutics is worth. Vivos Therapeutics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Vivos Therapeutics valuation ratios help investors to determine whether Vivos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vivos with respect to the benefits of owning Vivos Therapeutics security.

Vivos Therapeutics Valuation Data Chart

Market Cap is likely to drop to about 14.4 M in 2024. Enterprise Value is likely to drop to about 14.7 M in 2024

Working Capital

The difference between a company's current assets and current liabilities, indicating the liquidity and operational efficiency of the business.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Vivos Therapeutics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Vivos Therapeutics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Vivos Therapeutics value than its market capitalization because it takes into account all of Vivos Therapeutics existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vivos Stock Analysis

When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.